Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
Cancers|June 11, 2020
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall SurvivalChantal Bourrier, Jean-Yves Pierga, Laura Xuereb, et al.
Bulletin Du Cancer|May 6, 2011
[Survival of breast cancers patients with meningeal carcinoma]Hélène Petithuguenin Gauthier, Marie-Noëlle Guilhaume, François-Clément Bidard, et al.
British Journal of Cancer|February 21, 2018
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohortAnne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, et al.
Plos One|November 9, 2017
Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort studyFrançoise Laroche, Serge Perrot, Terkia Medkour, et al.
Plos One|August 6, 2016
Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving SurgeryMarie Gosset, Anne-Sophie Hamy, Peter Mallon, et al.
Biomicrofluidics|October 30, 2014
A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imagingGuillaume Mottet, Karla Perez-Toralla, Ezgi Tulukcuoglu, et al.
Biomed Research International|October 1, 2013
Helical tomotherapy for inoperable breast cancer: a new promising toolCiprian Chira, Youlia M Kirova, Xavier Liem, et al.
British Journal of Cancer|December 15, 2015
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohortAnne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, et al.
British Journal of Cancer|January 6, 2017
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survivalPauline Rochefort, Sylvie Chabaud, Jean-Yves Pierga, et al.
American Journal of Clinical Oncology|August 4, 2004
Breast cancer associated with idiopathic thrombocytopenic purpura: a single center series of 10 casesRégis Peffault de Latour, Gaëtan Des Guetz, Valérie Laurence, et al.
Pageof 25